ロード中...
The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
In 77 percent of patients suffering from a malignant carcinoid syndrome, administration of the somatostatin analog, octreotide (SMS 201-995, Sandostatin) induced clinical improvement coupled with a decrease in 24-hour urinary 5-hydroxyindole acetic acid (5-HIAA). This finding prompted an evaluation...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Yale Journal of Biology and Medicine
1992
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2589749/ https://ncbi.nlm.nih.gov/pubmed/1364090 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|